ADAMTS13 and hyperinsulinemic hypoglycemia, familial, 4: A therapeutic plasma exchange (TPE) or plasma infusion, allowing for an exogenous supply of ADAMTS13 deficiency and the saturation of anti-ADAMTS13 autoantibodies, is the first-line treatment for acute iTTP in children, as soon as an iTTP diagnosis is made or even suspected [27].